CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 151 filers reported holding CHEMOCENTRYX INC in Q2 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $467,000 | +418.9% | 33,500 | +10.2% | 0.03% | +520.0% |
| Q2 2022 | $90,000 | -88.3% | 30,400 | -63.6% | 0.01% | -83.9% |
| Q1 2022 | $766,000 | -29.7% | 83,536 | +0.5% | 0.03% | +3.3% |
| Q4 2021 | $1,090,000 | -15.3% | 83,152 | -16.0% | 0.03% | -26.8% |
| Q3 2021 | $1,287,000 | +53.6% | 99,016 | -46.1% | 0.04% | +51.9% |
| Q2 2021 | $838,000 | -82.7% | 183,609 | -67.9% | 0.03% | -89.8% |
| Q2 2020 | $4,831,000 | +1230.9% | 572,000 | +467.5% | 0.26% | +1004.2% |
| Q1 2020 | $363,000 | – | 100,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |